In a Class I recall, the most serious type, a New Jersey drugmaker is removing 17,376 drug cartons from the market because of a cross-contamination risk.
Three drugs have been listed as or reaffirmed as in shortage since Sept. 21, according to data from the FDA and the American Society of Health-System Pharmacists.
Louisville, Ky.-based Baptist Health is centralizing its supply chain operations to establish a consolidated pharmacy service center, according to an Oct. 4 news release.
As copay issues reportedly resolve for Americans receiving this season’s updated COVID-19 vaccine, nursing homes and pediatric officers are struggling as demand exceeds supply.
Hospira, a New York City-based Pfizer company, recalled two lots of lidocaine and one lot of sodium bicarbonate because vials could contain glass particles.
Apellis Pharmaceuticals, a biotech drug company based in Waltham, Mass., recalled more than 61,000 injection needle kits after eight retinal vasculitis cases were reported.
B. Braun Medical, a medical supply and pharmaceuticals company, is voluntarily recalling about 1.1 million syringes because of a possible sterility issue.